Upk1a/Upk1b staining was observed in 32% of GATA3 negative pT2-4 cancers and GATA3 staining was seen in 43% of Upk1a/Upk1b negative pT2-4 urothelial carcinomas. This evidence concerns the gene UPK1A and urothelial carcinoma.